|
|
Volumn 279, Issue 5351, 1998, Pages 646-648
|
|
After Dolly, a pharming frenzy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOTECHNOLOGY;
CELL NUCLEUS TRANSPLANTATION;
CLONING;
DRUG INDUSTRY;
FETUS CELL;
GENE DISRUPTION;
MEDICAL ETHICS;
NOTE;
PRIORITY JOURNAL;
TRANSGENIC ANIMAL;
ANIMAL EXPERIMENTATION;
ANIMAL ORGANS;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLONING;
GENETIC RESEARCH;
GENETICS AND REPRODUCTION;
INTERNATIONAL ASPECTS;
NETHERLANDS;
PHARMING HOLDING N.V.;
UNITED STATES;
ANIMAL EXPERIMENTATION;
ANIMALS;
ANIMALS, GENETICALLY MODIFIED;
BIOTECHNOLOGY;
CATTLE;
CLONING, ORGANISM;
FETUS;
GENETIC ENGINEERING;
GENETIC RESEARCH;
HUMANS;
INTERNATIONALITY;
NUCLEAR TRANSFER TECHNIQUES;
RECOMBINANT PROTEINS;
SHEEP;
SWINE;
TRANSPLANTATION, HETEROLOGOUS;
ANIMALIA;
|
|
EID: 0032579410
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.279.5351.646 Document Type: Note |
|
Times cited : (12)
|
|
References (0)
|